MN Rochester의 전이성 암 임상 시험
전이성 암 관련 연구 31개가 Rochester 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
피험자 모집 중2상
- Mayo Clinic in Rochester, Rochester
Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors
피험자 모집 중
- Mayo Clinic in Rochester, Rochester
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
피험자 모집 중2상
- Mayo Clinic in Rochester, Rochester
PRE-ISPY Phase I/II Oncology Platform Program
피험자 모집 중1/2상
- Mayo Clinic Comprehensive Cancer Center, Rochester
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
피험자 모집 중2/3상
- Mayo Clinic, Rochester
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
피험자 모집 중3상
- Mayo Clinic Hospital, Methodist Campus, Research Pharmacy, Rochester
- Mayo Clinic Pharmacy, Rochester
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- 외 3개
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
피험자 모집 중1상
- Mayo Clinic Rochester, Rochester
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
피험자 모집 중2/3상
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
피험자 모집 중2상
- Mayo Clinic Cancer Center, Rochester
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
피험자 모집 중3상
- Mayo Clinic in Rochester, Minnesota, Rochester
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
피험자 모집 중3상
- Mayo Clinic in Rochester, Minnesota, Rochester
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
피험자 모집 중2상
- Mayo Clinic Rochester, Rochester
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
피험자 모집 중1/2상
- Mayo Clinic Hospital, Methodist Campus, Research Pharmacy, Rochester
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
CREO - Microwave Ablation Feasibility Study
피험자 모집 중
- Mayo Clinic Rochester, Rochester
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
피험자 모집 중1상
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
피험자 모집 중1상
- Mayo Clinic - Rochester, Rochester
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
피험자 모집 중3상
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
피험자 모집 중2상
- Research Site, Rochester
FOG-001 in Locally Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Mayo Clinic, Rochester
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
피험자 모집 중1/2상
- Crinetics Study Site, Rochester
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Mayo Clinic (Minnesota), Rochester
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
피험자 모집 중1상
- Mayo Clinic, Rochester
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
피험자 모집 중관찰 연구
- Mayo Clinic in Rochester, Rochester
Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients
피험자 모집 중
- Mayo Clinic in Rochester, Rochester
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
피험자 모집 중관찰 연구
- Mayo Clinic in Rochester, Rochester
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
피험자 모집 중2/3상
- Mayo Clinic Comprehensive Cancer Center, Rochester
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
피험자 모집 중2/3상
- Mayo Clinic Rochester, Rochester
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
피험자 모집 중관찰 연구
- Mayo Clinic in Rochester, Rochester
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
피험자 모집 중3상
- Mayo Clinic - Rochester, Mn, Rochester
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
피험자 모집 중1/2상
- Mayo Clinic, Rochester
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
피험자 모집 중1/2상
- Mayo Clinic in Minnesota, Rochester
다른 도시의 전이성 암 시험
- Houston, TX연구 104개
- New York City, NY연구 93개
- Nashville, TN연구 70개
- Boston, MA연구 63개
- Los Angeles, CA연구 57개
- St. Louis, MO연구 54개
- Arlington, VA연구 53개
- Philadelphia, PA연구 46개
- Chicago, IL연구 45개
- San Antonio, TX연구 44개
- Washington, DC연구 43개
- Dallas, TX연구 42개
Rochester의 다른 연구
- 유방암연구 42개
- 비소세포폐암연구 37개
- 암 (전체)연구 30개
- 대장직장암연구 29개
- 난소암연구 29개
- 다발성 골수종연구 24개
- 전립선암연구 22개
- 심부전연구 22개
- 췌장암연구 22개
- 폐암연구 20개
- 자궁내막암연구 20개
- 만성 림프구성 백혈병연구 19개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.